Ryerson University’s MedTech Talent Accelerator, in association with McGill University’s Biological & Biomedical Engineering (BBME) Student Society, will be hosting a virtual 2-day Biomedical Engineering symposium on May 5-6, 2021.
As part of the program, a virtual panel discussion entitled ‘Explore Medtech: Combating COVID-19’ will be held May 6th, 2021 at 2:30 PM EDT – 3:30 PM EDT.
The MedTech Talent Accelerator is a training program designed to launch the next generation of industry-ready talent for the Canadian Medical Technology sector. The program is a collaboration between Ryerson, McGill, Biomedical Zone and Medtech Canada (the National Association of the Canadian Medical Technology Industries) and its member companies.
Speaker Bios:
Prof. Caroline Wagner is an assistant professor in the department of Bioengineering at McGill University. She received her B. Eng from McGill, and her M.Sc. and PhD in Mechanical Engineering from the Massachusetts Institute of Technology (MIT). Her research program focuses on understanding the interaction between pathogens and biological fluids, and modeling the effect of such interactions on population-level disease dynamics. During the Covid-19 pandemic, she has worked on mathematical simulations for future burden and timing of Covid-19 infections given different assumptions related to adaptive immune responses arising from vaccines and natural infections.
Prof. David Juncker is a professor and the Chair of the Biomedical Engineering department at McGill university. His lab is exploring various facets of miniaturization and integration in biology and medicine, which includes the conception, engineering and utilization of novel micro and nanotechnologies for manipulating, stimulating and studying oligonucleotides, proteins, cells, and tissues.
Prof. Donald Sheppard is a professor at McGill University and Chair for the Department of Microbiology & Immunology. His laboratory is involved in identifying the molecular mechanisms whereby pathogenic fungi cause human disease. His lab focuses on two pathogens, Candida albicans and Aspergillus fumigatus, both of which cause fatal infections in immunocompromised hosts.
Marc Saab is the founder and managing director of BML technology. BML Technology is a digital health services firm in Montreal, focused on the adoption of digital health technology in value-based healthcare and precision medicine. He is a talented and passionate business leader with 20 years’ experience in Medical Device, Digital Health and Consumer Wearable markets. He is also a Biomedical Engineer with a Master’s Degree in neurological (EEG) signal processing from McGill University Biomedical Engineering.
The rest of the BBME Symposium program includes a Women in STEM panel, Bioresource Engineering presentations, several theme speakers, and a keynote from Dr. Michael Snyder of the Department of Genetics of Stanford Medicine.
Register for the entire symposium here.
About BML Technology
BML Technology understands digital health. At the intersection of medical technology, clinical research and patient-centric healthcare BML drives the mainstream adoption of digital technology in healthcare. Offering a full range of services to the digital health ecosystem BML manages the complex stakeholder interactions necessary to get digital health solutions to market and gain adoption.
Stay Connected with BML Technology.
Connect with BML Technology on LinkedIn.
Connect with Medtech Talent Accelerator on LinkedIn.
